Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares OutstandingShares Outstanding
Ratios

Bioregenx (BRGX) Non-Current Receivables (2023 - 2024)

Bioregenx has reported Non-Current Receivables over the past 2 years, most recently at $454766.0 for Q1 2024.

  • For Q1 2024, Non-Current Receivables changed N/A year-over-year to $454766.0; the TTM value through Mar 2024 reached $454766.0, changed N/A, while the annual FY2023 figure was $454371.0, N/A changed from the prior year.
  • Non-Current Receivables for Q1 2024 was $454766.0 at Bioregenx, roughly flat from $454371.0 in the prior quarter.
  • Over five years, Non-Current Receivables peaked at $454766.0 in Q1 2024 and troughed at $454371.0 in Q4 2023.